{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T16:47:33Z","timestamp":1795193253969,"version":"4.10.3"},"reference-count":103,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The clinicopathological and molecular characteristics of early-onset colorectal cancer (EOCRC) are unclear. In this study, we compared the clinicopathological features, biomarkers, and prognoses between EOCRC and late-onset colorectal cancer (LOCRC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A search was conducted on PubMed, Web of Science, Embase, and Cochrane Library from inception to May 2024. The key outcomes were clinicopathological features, prevalence of molecular biomarker alterations, and 5-year overall survival (OS), with pooled odds ratios (ORs) and hazard ratios (HRs), along with their corresponding 95% confidence intervals (CIs), calculated for each outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Forty studies were included in the final analysis. EOCRC exhibited distal colon and rectum localization (OR: 0.59; 95% CI: 0.55\u20130.62;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), was poorly differentiated (OR: 0.56; 95% CI: 0.52\u20130.60;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01), tended to be more mucinous or signet-ring cell carcinoma (OR: 0.56; 95% CI: 0.52\u20130.60;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and was associated with advanced stages (OR: 1.49; 95% CI: 1.30\u20131.71;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), lymph node metastasis (LNM) (OR: 0.56; 95% CI: 0.53\u20130.60;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and distant metastasis (OR: 1.29; 95% CI: 1.04\u20131.60;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02). EOCRC exhibited higher TP53 mutation rates (OR: 1.33; 95% CI: 1.13\u20131.58;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), MSI-H status (OR: 1.45; 95% CI: 1.10\u20131.92;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01), but lower PIK3CA mutation rates (OR: 0.93; 95% CI: 0.88\u20130.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03). EOCRC and LOCRC had similar 5-year OS rates (HR: 1.01; 95% CI: 0.79\u20131.30;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.92). Although no significant difference was observed in the APC, BRAF, KRAS, NRAS, SM4D4, and MMR, subgroup analyses revealed that BRAF (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01), KRAS mutations (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001), and DNA hypermethylation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01) were less prevalent among westerners.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>EOCRC often presents with more aggressive and metastatic features due to its frequent diagnosis at advanced stages. TP53 mutations and the MSI-H status are prevalent in EOCRC. EOCRC\u2019s prognosis is often comparable to LOCRC. Radical and tailored treatment strategies should be developed to improve the survival outcomes in advanced and metastatic EOCRC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003463","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:30:49Z","timestamp":1758033049000},"page":"1840-1854","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Clinicopathological characteristics and biomarker alterations in early-onset vs. late-onset colorectal cancer: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"112","author":[{"given":"Qiu-Shi","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second People\u2019s Hospital,Chengdu Second People\u2019s Hospital, Chengdu, China"},{"name":"Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Zhe","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Bin","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, West China School of Medicine, Sichuan University, Sichuan University Affiliated Chengdu Second People\u2019s Hospital,Chengdu Second People\u2019s Hospital, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"R1-20260518","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"230\u201343","DOI":"10.1038\/s41571-020-00445-1","article-title":"Rising incidence of early-onset colorectal cancer \u2013 a call to action","volume":"18","author":"Akimoto","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"1820\u201326","DOI":"10.1136\/gutjnl-2018-317592","article-title":"Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years","volume":"68","author":"Vuik","year":"2019","journal-title":"Gut"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cgh.2022.12.006","article-title":"Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) international management guidelines","volume":"21","author":"Cavestro","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"2179\u201385","DOI":"10.1136\/gutjnl-2019-319511","article-title":"Global patterns and trends in colorectal cancer incidence in young adults","volume":"68","author":"Siegel","year":"2019","journal-title":"Gut"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"1275\u201382","DOI":"10.1158\/1055-9965.EPI-18-1111","article-title":"Global increasing incidence of young-onset colorectal cancer across 5 continents: a Joinpoint regression analysis of 1,922,167 cases","volume":"28","author":"Lui","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"djw322","DOI":"10.1093\/jnci\/djw322","article-title":"Colorectal cancer incidence patterns in the United States, 1974-2013","volume":"109","author":"Siegel","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"17\u201322","DOI":"10.1001\/jamasurg.2014.1756","article-title":"Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010","volume":"150","author":"Bailey","year":"2015","journal-title":"JAMA Surg"},{"key":"R9-20260518","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12943-024-02133-5","article-title":"Charting the metabolic biogeography of the colorectum in cancer: challenging the right sided versus left sided classification","volume":"23","author":"Jain","year":"2024","journal-title":"Mol Cancer"},{"key":"R10-20260518","doi-asserted-by":"crossref","first-page":"2002\u201310","DOI":"10.1002\/cncr.31994","article-title":"Clinical and molecular characterization of early-onset colorectal cancer","volume":"125","author":"Willauer","year":"2019","journal-title":"Cancer"},{"key":"R11-20260518","doi-asserted-by":"crossref","first-page":"749\u201355","DOI":"10.1007\/s10147-021-02101-9","article-title":"Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location","volume":"27","author":"Chen","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"880\u201388","DOI":"10.1002\/jso.26797","article-title":"Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years","volume":"125","author":"Narayan","year":"2022","journal-title":"J Surg Oncol"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"797\u2013804","DOI":"10.1038\/s41416-020-01169-w","article-title":"The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients","volume":"124","author":"J\u00e1come","year":"2021","journal-title":"Br J Cancer"},{"key":"R14-20260518","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12943-018-0923-9","article-title":"Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles","volume":"17","author":"Imperial","year":"2018","journal-title":"Mol Cancer"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"1288\u2013301","DOI":"10.4251\/wjgo.v13.i10.1288","article-title":"Molecular testing for colorectal cancer: clinical applications","volume":"13","author":"Imyanitov","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"1365762","DOI":"10.3389\/fonc.2024.1365762","article-title":"Identification of differentially expressed genes and splicing events in early-onset colorectal cancer","volume":"14","author":"Marx","year":"2024","journal-title":"Front Oncol"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.3390\/cancers16112004","article-title":"Survival analysis of metastatic early-onset colorectal cancer compared to metastatic average-onset colorectal cancer: a SEER DATABASE analysis","volume":"16","author":"Jeri-Yabar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"4559\u201370","DOI":"10.1097\/JS9.0000000000001584","article-title":"Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study","volume":"110","author":"Tang","year":"2024","journal-title":"Int J Surg"},{"key":"R19-20260518","first-page":"464\u201371","article-title":"Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer","volume":"3","author":"Pearlman","year":"2017","journal-title":"JAMA Oncol"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"1137\u201343","DOI":"10.1016\/j.surg.2023.01.018","article-title":"Characteristics and symptomatology of colorectal cancer in the young","volume":"173","author":"Skalitzky","year":"2023","journal-title":"Surgery"},{"key":"R21-20260518","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1038\/s41467-019-11530-0","article-title":"Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients","volume":"10","author":"Serebriiskii","year":"2019","journal-title":"Nat Commun"},{"key":"R22-20260518","doi-asserted-by":"crossref","first-page":"1014\u201318","DOI":"10.1016\/j.amjsurg.2015.08.031","article-title":"Rectal cancer in patients under the age of 50 years: the delayed diagnosis","volume":"211","author":"Scott","year":"2016","journal-title":"Am J Surg"},{"key":"R23-20260518","doi-asserted-by":"crossref","first-page":"521\u201332","DOI":"10.1016\/j.dld.2018.02.009","article-title":"Early onset sporadic colorectal cancer: worrisome trends and oncogenic features","volume":"50","author":"Cavestro","year":"2018","journal-title":"Dig Liver Dis"},{"key":"R24-20260518","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"R25-20260518","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"Bmj"},{"key":"R26-20260518","first-page":"100082","article-title":"Transparency in the reporting of artificial intelligence \u2013 the TITAN guideline","volume":"10","author":"Riaz","journal-title":"Prem J Sci 2025"},{"key":"R27-20260518","doi-asserted-by":"crossref","first-page":"4883\u201393","DOI":"10.2217\/fon-2021-0650","article-title":"Age-dependent prognostic value of KRAS mutation in metastatic colorectal cancer","volume":"17","author":"Ozer","year":"2021","journal-title":"Future Oncol"},{"key":"R28-20260518","doi-asserted-by":"crossref","first-page":"457\u201362","DOI":"10.1016\/j.arcmed.2011.09.008","article-title":"Analysis of DNA mismatch repair proteins expression and BRAF V600E mutation in a subset of early- and late-onset colorectal carcinoma patients in Mexico","volume":"42","author":"Lu\u00e9vano-Gonz\u00e1lez","year":"2011","journal-title":"Arch Med Res"},{"key":"R29-20260518","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00384-024-04604-z","article-title":"Association between microsatellite status and characteristics and outcomes of early-onset compared to late-onset rectal cancer","volume":"39","author":"Emile","year":"2024","journal-title":"Int J Colorectal Dis"},{"key":"R30-20260518","doi-asserted-by":"crossref","first-page":"48\u201354","DOI":"10.1038\/s41416-021-01300-5","article-title":"Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort","volume":"125","author":"Chen","year":"2021","journal-title":"Br J Cancer"},{"key":"R31-20260518","doi-asserted-by":"crossref","first-page":"1374\u201382","DOI":"10.3390\/cimb46020088","article-title":"Association of KRAS G12C Status with Age at Onset of Metastatic Colorectal Cancer","volume":"46","author":"Sunagua Aruquipa","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"R32-20260518","doi-asserted-by":"crossref","first-page":"191\u201397","DOI":"10.1093\/oncolo\/oyab055","article-title":"BRAF mutations are associated with poor survival outcomes in advanced-stage mismatch repair-deficient\/microsatellite high colorectal cancer","volume":"27","author":"Tan","year":"2022","journal-title":"Oncologist"},{"key":"R33-20260518","doi-asserted-by":"crossref","first-page":"21\u201326","DOI":"10.1097\/DCR.0000000000001188","article-title":"A changing spectrum of colorectal cancer biology with age: implications for the young patient","volume":"62","author":"Chouhan","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"R34-20260518","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3390\/cells10030631","article-title":"Clinical, pathological and molecular characteristics of chilean patients with early-, intermediate- and late-onset colorectal cancer","volume":"10","author":"Alvarez","year":"2021","journal-title":"Cells"},{"key":"R35-20260518","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.3390\/cancers15174242","article-title":"Clinico-pathological features, outcomes and impacts of COVID-19 pandemic on patients with early-onset colorectal cancer: a single-institution experience","volume":"15","author":"Martinez-Perez","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R36-20260518","doi-asserted-by":"crossref","first-page":"10732748221096842","DOI":"10.1177\/10732748221096842","article-title":"Clinicogenomic characteristics and treatment of young-onset colorectal cancer patients treated with palliative therapy in real-world practice","volume":"29","author":"Jeong","year":"2022","journal-title":"Cancer Control"},{"key":"R37-20260518","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12885-021-09132-5","article-title":"Colorectal cancer in north-eastern iran: a retrospective, comparative study of early-onset and late-onset cases based on data from the iranian hereditary colorectal cancer registry","volume":"22","author":"Hoseini","year":"2022","journal-title":"BMC Cancer"},{"key":"R38-20260518","doi-asserted-by":"crossref","first-page":"164\u201375","DOI":"10.4240\/wjgs.v13.i2.164","article-title":"Colorectal cancer of the young displays distinct features of aggressive tumor biology: a single-center cohort study","volume":"13","author":"Mueller","year":"2021","journal-title":"World J Gastrointest Surg"},{"key":"R39-20260518","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.3390\/cancers15143570","article-title":"Completion of genetic testing and incidence of pathogenic germline mutation among patients with early-onset colorectal cancer: a single institution analysis","volume":"15:","author":"Storandt","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R40-20260518","doi-asserted-by":"crossref","first-page":"1683\u201392","DOI":"10.1093\/jnci\/djab124","article-title":"A comprehensive comparison of early-onset and average-onset colorectal cancers","volume":"113","author":"Cercek","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"R41-20260518","doi-asserted-by":"crossref","first-page":"e0218604","DOI":"10.1371\/journal.pone.0218604","article-title":"Differences in biological behaviors between young and elderly patients with colorectal cancer","volume":"14","author":"Cheong","year":"2019","journal-title":"PLoS One"},{"key":"R42-20260518","doi-asserted-by":"crossref","first-page":"857\u201363","DOI":"10.1016\/j.ejso.2021.10.021","article-title":"Early age of onset is an independent predictor for worse disease-free survival in sporadic rectal cancer patients. A comparative analysis of 980 consecutive patients","volume":"48","author":"Foppa","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"R43-20260518","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3390\/cancers15030889","article-title":"Early Onset colorectal cancer in arabs, are we dealing with a distinct disease?","volume":"15","author":"Al Zaabi","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R44-20260518","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fgene.2020.00096","article-title":"Effect of tumor location on clinicopathological and molecular markers in colorectal cancer in Eastern China patients: an analysis of 2,356 cases","volume":"11","author":"Song","year":"2020","journal-title":"Front Genet"},{"key":"R45-20260518","first-page":"153\u201359","article-title":"Impact of institutional universal microsatellite-instability (MSI) reflex testing on molecular profiling differences between younger and older patients with colorectal cancer","volume":"22","author":"Altshuler","year":"2023","journal-title":"Clin Colorectal Cancer"},{"key":"R46-20260518","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/ijms18071441","article-title":"Molecular and clinicopathological differences by age at the diagnosis of colorectal cancer","volume":"18","author":"Chang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R47-20260518","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/medicina59030489","article-title":"The importance of immunohistochemical heterogeneous expression of MMR protein in patients with colorectal cancer in stage II and III of the disease","volume":"59","author":"Den\u010di\u0107","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"R48-20260518","doi-asserted-by":"crossref","first-page":"88\u201399","DOI":"10.1053\/j.gastro.2014.09.041","article-title":"Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes","volume":"148","author":"Sinicrope","year":"2015","journal-title":"Gastroenterology"},{"key":"R49-20260518","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12032-014-0124-3","article-title":"Molecular spectrum of KRAS, BRAF, and PIK3CA gene mutation: determination of frequency, distribution pattern in Indian colorectal carcinoma","volume":"31","author":"Bisht","year":"2014","journal-title":"Med Oncol"},{"key":"R50-20260518","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3892\/mco.2021.2409","article-title":"Real-world outcome of universal screening for Lynch syndrome in Japanese patients with colorectal cancer highlights the importance of targeting patients with young-onset disease","volume":"15","author":"Yamada","year":"2021","journal-title":"Mol Clin Oncol"},{"key":"R51-20260518","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12885-024-12278-7","article-title":"Comparative characteristics of early-onset vs. late-onset advanced colorectal cancer: a nationwide study in China","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"key":"R52-20260518","doi-asserted-by":"crossref","first-page":"e2345801","DOI":"10.1001\/jamanetworkopen.2023.45801","article-title":"KRAS sequence variation as prognostic marker in patients with young- vs late-onset colorectal cancer","volume":"6","author":"Aljehani","year":"2023","journal-title":"JAMA Network Open"},{"key":"R53-20260518","doi-asserted-by":"crossref","first-page":"e2324038","DOI":"10.1001\/jamanetworkopen.2023.24038","article-title":"Synchronous neoplasia rates at colonoscopic diagnosis of early-onset vs average-onset colorectal cancer","volume":"6","author":"Emiloju","year":"2023","journal-title":"JAMA Network Open"},{"key":"R54-20260518","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00384-023-04317-9","article-title":"The prognostic significance of clinicopathological characteristics in early-onset versus late-onset colorectal cancer liver metastases","volume":"38","author":"Li","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"R55-20260518","doi-asserted-by":"crossref","first-page":"106780","DOI":"10.1016\/j.ijsu.2022.106780","article-title":"Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: a retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center","volume":"104","author":"Gao","year":"2022","journal-title":"Int J Surg"},{"key":"R56-20260518","first-page":"2833","article-title":"A population-based study of age-related variation in clinicopathological features, molecular. Markers and outcome from colorectal cancer","volume":"27","author":"Morris","year":"2007","journal-title":"Anticancer Res"},{"key":"R57-20260518","doi-asserted-by":"crossref","first-page":"1282\u201393","DOI":"10.1158\/2159-8290.CD-21-0813","article-title":"The genomics of colorectal cancer in populations with African and European Ancestry","volume":"12","author":"Myer","year":"2022","journal-title":"Cancer Discov"},{"key":"R58-20260518","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/genes14040894","article-title":"Molecular and Sociodemographic Colorectal Cancer disparities in latinos living in puerto rico","volume":"14","author":"Perez-Mayoral","year":"2023","journal-title":"Genes (Basel)"},{"key":"R59-20260518","doi-asserted-by":"crossref","first-page":"712\u201326","DOI":"10.14309\/ajg.0000000000002171","article-title":"Molecular characteristics of early-onset colorectal cancer according to detailed anatomical locations: comparison with later-onset cases","volume":"118","author":"Ugai","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"R60-20260518","first-page":"5571\u201380","article-title":"Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer","volume":"11","author":"Liao","year":"2021","journal-title":"Am J Cancer Res"},{"key":"R61-20260518","doi-asserted-by":"crossref","first-page":"2109\u201317","DOI":"10.1002\/ijc.31973","article-title":"Demographic trends and KRAS\/BRAF(V600E) mutations in colorectal cancer patients of South China: a single-site report","volume":"144","author":"Fu","year":"2019","journal-title":"Int, J, Cancer"},{"key":"R62-20260518","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/diagnostics12061395","article-title":"Nomogram predicting the survival of young-onset patients with colorectal cancer liver metastases","volume":"12","author":"Cheng","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R63-20260518","doi-asserted-by":"crossref","first-page":"102821","DOI":"10.1016\/j.ctrv.2024.102821","article-title":"Early-onset colorectal cancer: from the laboratory to the clinic","volume":"130","author":"Gandini","year":"2024","journal-title":"Cancer Treat Rev"},{"key":"R64-20260518","doi-asserted-by":"crossref","first-page":"e30979","DOI":"10.1097\/MD.0000000000030979","article-title":"KRAS,NRAS,BRAF, PIK3CA, and AKT1 signatures in colorectal cancer patients in south-eastern romania","volume":"101","author":"Brinzan","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R65-20260518","first-page":"293\u2013300","article-title":"Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine","volume":"9","author":"Nishiyama","year":"2002","journal-title":"Oncol Rep"},{"key":"R66-20260518","first-page":"10732748241262179","article-title":"KRAS","volume":"31","author":"El Zaitouni","year":"2024","journal-title":"NRAS and BRAF Mutational Profile of Colorectal Cancer in a Series of Moroccan Patients Cancer Control"},{"key":"R67-20260518","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/14622416.2025.2479414","article-title":"Treatment of extended RAS\/BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations","volume":"26","author":"Voutsadakis","year":"2025","journal-title":"Pharmacogenomics"},{"key":"R68-20260518","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/cancers16051029","article-title":"Recent Advances in therapeutic strategies to improve colorectal cancer treatment","volume":"16","author":"Gmeiner","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R69-20260518","doi-asserted-by":"crossref","first-page":"6513\u201323","DOI":"10.1158\/0008-5472.CAN-17-0768","article-title":"Mechanisms of acquired resistance to BRAF V600E inhibition in colon cancers converge on RAF dimerization and are sensitive to its inhibition","volume":"77","author":"Yaeger","year":"2017","journal-title":"Cancer Res"},{"key":"R70-20260518","doi-asserted-by":"crossref","first-page":"21\u201335","DOI":"10.1016\/j.neo.2020.11.005","article-title":"Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine","volume":"23","author":"Rivera","year":"2021","journal-title":"Neoplasia"},{"key":"R71-20260518","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1186\/s12885-023-11600-z","article-title":"Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis","volume":"23","author":"Lu","year":"2023","journal-title":"BMC Cancer"},{"key":"R72-20260518","doi-asserted-by":"crossref","first-page":"922\u201329","DOI":"10.1002\/ijc.30507","article-title":"EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS \/ BRAF \/ PIK3CA wild type metastatic colorectal cancer","volume":"140","author":"\u00c5lgars","year":"2017","journal-title":"Int, J, Cancer"},{"key":"R73-20260518","doi-asserted-by":"crossref","first-page":"116393","DOI":"10.1016\/j.bcp.2024.116393","article-title":"Early onset colorectal cancer: cancer promotion in young tissue","volume":"226","author":"Giardina","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"R74-20260518","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3390\/cancers13092125","article-title":"The role of p53 signaling in colorectal cancer","volume":"13","author":"Liebl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R75-20260518","doi-asserted-by":"crossref","first-page":"2548\u201355","DOI":"10.1245\/s10434-016-5205-4","article-title":"KRAS and combined KRAS\/TP53 mutations in locally advanced rectal cancer are independently associated with decreased response to neoadjuvant therapy","volume":"23","author":"Chow","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"R76-20260518","doi-asserted-by":"crossref","first-page":"961350","DOI":"10.3389\/fimmu.2022.961350","article-title":"Integrated single-cell RNA-seq analysis identifies immune heterogeneity associated with KRAS\/TP53 mutation status and tumor-sideness in colorectal cancers","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"R77-20260518","doi-asserted-by":"crossref","first-page":"1467\u201380","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"R78-20260518","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/s12885-021-08362-x","article-title":"Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours","volume":"21","author":"Dhaka","year":"2021","journal-title":"BMC Cancer"},{"key":"R79-20260518","doi-asserted-by":"crossref","first-page":"5318\u201324","DOI":"10.1158\/1078-0432.CCR-07-5136","article-title":"Targeting the MDM2-p53 interaction for cancer therapy","volume":"14","author":"Shangary","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R80-20260518","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/cancers15041022","article-title":"Challenges and Therapeutic Opportunities in the dMMR\/MSI-H Colorectal Cancer Landscape","volume":"15","author":"Mulet-Margalef","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R81-20260518","doi-asserted-by":"crossref","first-page":"2207\u201318","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"key":"R82-20260518","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13148-023-01514-9","article-title":"DNA methylation alterations at RE1-silencing transcription factor binding sites and their flanking regions in cancer","volume":"15","author":"Vega-Benedetti","year":"2023","journal-title":"Clin Clin Epigenet"},{"key":"R83-20260518","doi-asserted-by":"crossref","first-page":"1900\u201314","DOI":"10.1002\/cbin.11868","article-title":"DNA methylation influences the CTCF-modulated transcription of RASSF1A in lung cancer cells","volume":"46","author":"Xie","year":"2022","journal-title":"Cell Biol Int"},{"key":"R84-20260518","doi-asserted-by":"crossref","first-page":"153009","DOI":"10.1016\/j.prp.2020.153009","article-title":"Potential of RASSF1A promoter methylation as a biomarker for colorectal cancer: meta-analysis and TCGA analysis","volume":"216","author":"Hu","year":"2020","journal-title":"Pathol Res Pract"},{"key":"R85-20260518","doi-asserted-by":"crossref","first-page":"3271\u201379","DOI":"10.1158\/1078-0432.CCR-19-3728","article-title":"Mismatch repair-deficient rectal cancer and resistance to neoadjuvant chemotherapy","volume":"26","author":"Cercek","year":"2020","journal-title":"Clin Cancer Res"},{"key":"R86-20260518","doi-asserted-by":"crossref","first-page":"4279\u201389","DOI":"10.1200\/JCO.22.02378","article-title":"Clinical multigene panel testing identifies racial and ethnic differences in germline pathogenic variants among patients with early-onset colorectal cancer","volume":"41","author":"Seagle","year":"2023","journal-title":"J Clin Oncol"},{"key":"R87-20260518","doi-asserted-by":"crossref","first-page":"1128\u201339","DOI":"10.1038\/modpathol.2012.61","article-title":"Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features","volume":"25","author":"Chang","year":"2012","journal-title":"Mod Pathol"},{"key":"R88-20260518","doi-asserted-by":"crossref","first-page":"124\u201338","DOI":"10.3748\/wjg.v24.i1.124","article-title":"Systematic review of colorectal cancer screening guidelines for average-risk adults: summarizing the current global recommendations","volume":"24","author":"B\u00e9nard","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R89-20260518","first-page":"865\u201374","article-title":"Characteristics of early-onset vs late-onset colorectal cancer: a review","volume":"156","author":"Zaborowski","year":"2021","journal-title":"JAMA Surg"},{"key":"R90-20260518","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12876-019-0965-5","article-title":"Impact of primary colorectal Cancer location on the KRAS status and its prognostic value","volume":"19","author":"Xie","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R91-20260518","doi-asserted-by":"crossref","first-page":"411\u201319","DOI":"10.6004\/jnccn.2017.0038","article-title":"Right versus left colon cancer biology: integrating the consensus molecular subtypes","volume":"15","author":"Lee","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"R92-20260518","doi-asserted-by":"crossref","first-page":"1055\u201366","DOI":"10.1016\/S1470-2045(25)00239-6","article-title":"Patterns in genomic mutations among patients with early-onset colorectal cancer: an international, multicohort, observational study","volume":"26","author":"Li","year":"2025","journal-title":"Lancet Oncol"},{"key":"R93-20260518","doi-asserted-by":"crossref","first-page":"37\u201352","DOI":"10.1016\/j.semcancer.2018.05.002","article-title":"Molecular subtyping of colorectal cancer: recent progress, new challenges and emerging opportunities","volume":"55","author":"Wang","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"R94-20260518","doi-asserted-by":"crossref","first-page":"e2100245","DOI":"10.1200\/PO.21.00245","article-title":"Landscape of KRAS(G12C), associated genomic alterations, and interrelation with immuno-oncology biomarkers in KRAS-mutated cancers","volume":"6","author":"Salem","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"R95-20260518","doi-asserted-by":"crossref","first-page":"21\u201327","DOI":"10.1007\/s00428-016-2042-6","article-title":"Adequately defining tumor cell proportion in tissue samples for molecular testing improves interobserver reproducibility of its assessment","volume":"470","author":"Lhermitte","year":"2017","journal-title":"Virchows Arch"},{"key":"R96-20260518","doi-asserted-by":"crossref","first-page":"301\u201309","DOI":"10.1002\/bjs.11333","article-title":"Population-based analysis of outcomes with early-age colorectal cancer","volume":"107","author":"Saraste","year":"2020","journal-title":"Br J Surg"},{"key":"R97-20260518","doi-asserted-by":"crossref","first-page":"402\u201309","DOI":"10.1001\/jamasurg.2014.3572","article-title":"Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains","volume":"150","author":"Kneuertz","year":"2015","journal-title":"JAMA Surg"},{"key":"R98-20260518","doi-asserted-by":"crossref","first-page":"929\u201334","DOI":"10.1002\/cncr.29716","article-title":"Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening","volume":"122","author":"Abdelsattar","year":"2016","journal-title":"Cancer"},{"key":"R99-20260518","doi-asserted-by":"crossref","first-page":"3510\u201319","DOI":"10.1002\/cncr.31527","article-title":"Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease","volume":"124","author":"Kolarich","year":"2018","journal-title":"Cancer"},{"key":"R100-20260518","doi-asserted-by":"crossref","first-page":"2334\u201339","DOI":"10.1200\/JCO.2011.41.1975","article-title":"Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the adjuvant colon cancer endpoints data set","volume":"30","author":"Hubbard","year":"2012","journal-title":"J Clin Oncol"},{"key":"R101-20260518","doi-asserted-by":"crossref","first-page":"1558\u201370","DOI":"10.3390\/curroncol28030147","article-title":"Canadian colorectal cancer screening guidelines: do they need an update given changing incidence and global practice patterns?","volume":"28","author":"Kalyta","year":"2021","journal-title":"Curr Oncol"},{"key":"R102-20260518","doi-asserted-by":"crossref","first-page":"2152\u201366","DOI":"10.1136\/gutjnl-2022-327377","article-title":"Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance","volume":"71","author":"Sung","year":"2022","journal-title":"Gut"},{"key":"R103-20260518","first-page":"285\u201399","article-title":"Updates on age to start and stop colorectal cancer screening: recommendations From the U.S. multi-society task force on colorectal cancer","volume":"162","author":"Patel","year":"2022","journal-title":"Gastroenterology"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:19:34Z","timestamp":1779110374000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003463","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"2025-04-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}